Back

Ongoing preclinical and clinical trials on FXIa and FXIIa

22 October 2022 (10:07 - 10:30)
Organised by: Logo
Seminar Presentation Part of: Update on antithrombotic strategies Thrombosis, Bleeding Open Access EuroThrombosis and EuroVessels 2022 WG on Thrombosis

About the speaker

Photo
Professor Hugo Ten Cate

Maastricht University Medical Centre (MUMC), Maastricht (Netherlands (The))

3 More presentations in this session

Presentation thumbnail
Antithrombotic strategies after AMI
Professor C. Gavina (Porto, PT)
Presentation thumbnail
Dual pathway in atherothrombotic disorders
Professor J. Morais (Leiria, PT)
Presentation thumbnail
Management of anti-thrombotic treatment in patients undergoing non-cardiac surgery
Professor S. Halvorsen (Oslo, NO)

Access the full session

Session thumbnail
Update on antithrombotic strategies

The Event

Event poster

EuroThrombosis and EuroVessels 2022

22 October 2022 10:07 CET
You may be interested in
thumbnail
Congress Session
The new frontier in oral anticoagulation: Factor XIa inhibitors
16 April 2023
thumbnail
Congress Session
Young Investigator Award Basic and Translational Science
1 April 2025
thumbnail
Congress Presentation
Factor XI inhibitors or direct oral anticoagulants in atrial fibrillation: an updated meta-analysis
1 September 2025
thumbnail
Webinar
Are NOACs already outdated? New trends in anticoagulation therapy
12 December 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources